A phase 2 study of botensilimab and AGEN1423, an anti-CD73-TGFβ-trap bifunctional antibody, in subjects with advanced pancreatic cancer.

Bibliographic Details
Published in:Journal of Clinical Oncology Vol. 44; pp. 702 - 847
Main Authors: Berg, Julia, Bullock, Andrea J., Whooley, Peter D., Peters, Mary Linton Bounetheau, Horick, Nora K., Zerillo, Jessica Ann, Rattani, Ahmed Anwer Ali, Schlechter, Benjamin L., Sinanovic, Selma, Martin, Jane, Montgomery, Casey, Eaton, Elizabeth, Vyas, Monika, Muranen, Taru E., Hidalgo, Manuel, Bockorny, Bruno
Format: Journal Article
Published: American Society of Clinical Oncology 2026 Supplsmsnr 2
Online Access:View this record in EBSCOhost